Menu
  • Home
  • Overview
  • Science
  • Pipeline
  • Leadership
  • News
Skip to content
Carl Genberg - Kinnear Pharmaceuticals Carl Genberg - Kinnear Pharmaceuticals

Kinnear Pharmaceuticals


  • Home
  • Overview
  • Science
  • Pipeline
  • Leadership
  • News

Kinnear Pharmaceuticals

Author: Carl Genberg

Published Research Shows CSA-131’s Potent Efficacy against Global Health Threat

Posted on April 5, 2018 by Carl Genberg

New Publication regarding Ceragenin CSA-131’s Potent Efficacy against fungal pathogen Candida auris, a New Serious Global Health Threat

N8 Medical News

Colistin Resistance on the Rise

Posted on July 12, 2016 by Carl Genberg

Colistin is the last agent used to combat bacteria that are resistant to the strongest antibiotics. Colistin has remained the best tool available to treat multidrug resistant bacteria because bacteria

Read More
N8 Medical News

CSA-131 Highly Effective against Colistin-resistant Strains

Posted on September 7, 2015 by Carl Genberg

A recent published study by Professor Jordi Vila and his colleagues at the University of Barcelona, Spain has found that CSA-131 is highly effective against Colistin resistant strains of Pseudomonas

Read More
N8 Medical News
Built with BoldGridPowered By DreamHost
Menu
  • Home
  • Overview
  • Science
  • Pipeline
  • Leadership
  • News

©2019 Kinnear Pharmaceuticals, LLC